Cargando…
Characterization of interaction between blood coagulation factor VIII and LRP1 suggests dynamic binding by alternating complex contacts
BACKGROUND: Deficiency in blood coagulation factor VIII (FVIII) results in life‐threating bleeding (hemophilia A) treated by infusions of FVIII concentrates. To improve disease treatment, FVIII has been modified to increase its plasma half‐life, which requires understanding mechanisms of FVIII catab...
Autores principales: | Chun, Haarin, Kurasawa, James H., Olivares, Philip, Marakasova, Ekaterina S., Shestopal, Svetlana A., Hassink, Gabriela U., Karnaukhova, Elena, Migliorini, Mary, Obi, Juliet O., Smith, Ally K., Wintrode, Patrick L., Durai, Prasannavenkatesh, Park, Keunwan, Deredge, Daniel, Strickland, Dudley K., Sarafanov, Andrey G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804390/ https://www.ncbi.nlm.nih.gov/pubmed/35810466 http://dx.doi.org/10.1111/jth.15817 |
Ejemplares similares
-
Molecular chaperone RAP interacts with LRP1 in a dynamic bivalent mode and enhances folding of ligand-binding regions of other LDLR family receptors
por: Marakasova, Ekaterina, et al.
Publicado: (2021) -
Isolated Variable Domains of an Antibody Can Assemble on Blood Coagulation Factor VIII into a Functional Fv-like Complex
por: Shestopal, Svetlana A., et al.
Publicado: (2022) -
Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach
por: Winterling, Karina, et al.
Publicado: (2021) -
The factor VIII treatment history of non‐severe hemophilia A
por: Abdi, Amal, et al.
Publicado: (2020) -
Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation
por: Valke, Lars L.F.G., et al.
Publicado: (2020)